Publication:
Efficacy and safety of dihydroartemisinin-piperaquine

dc.contributor.authorH. Y. Myinten_US
dc.contributor.authorE. A. Ashleyen_US
dc.contributor.authorN. P J Dayen_US
dc.contributor.authorF. Nostenen_US
dc.contributor.authorN. J. Whiteen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherEpicentreen_US
dc.contributor.otherChurchill Hospitalen_US
dc.contributor.otherShoklo Malaria Research Uniten_US
dc.date.accessioned2018-08-24T01:52:07Z
dc.date.available2018-08-24T01:52:07Z
dc.date.issued2007-09-01en_US
dc.description.abstractDihydroartemisinin-piperaquine, a fixed-dose combination antimalarial, is an inexpensive, safe and highly effective treatment for uncomplicated falciparum or vivax malaria. Efficacy assessed over 28-63 days has consistently exceeded 95% in the treatment of multidrug-resistant falciparum malaria. More than 2600 patients have been treated with this combination in prospective studies, mainly in Southeast Asia. Tolerability was uniformly good, and no serious adverse effects have been identified. The dosing regimen has been simplified from four doses to once daily over 3 days. More information on efficacy in Africa, and more pharmacokinetic and efficacy data in children are needed. © 2007 Royal Society of Tropical Medicine and Hygiene.en_US
dc.identifier.citationTransactions of the Royal Society of Tropical Medicine and Hygiene. Vol.101, No.9 (2007), 858-866en_US
dc.identifier.doi10.1016/j.trstmh.2007.05.018en_US
dc.identifier.issn00359203en_US
dc.identifier.other2-s2.0-34447617873en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/24519
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34447617873&origin=inwarden_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleEfficacy and safety of dihydroartemisinin-piperaquineen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34447617873&origin=inwarden_US

Files

Collections